Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review)
Oncology Reports · 30.12.2024 · 53 (2)
DOI: 10.3892/or.2024.8862 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 30.12.2024. Verfasst von Sirui Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiration, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430077, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Tumor Microenvironment, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiration, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430077, P.R. China.
- Department of Orthopedics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430077, P.R. China.
- Department of Radiation Oncology, Minda Hospital of Hubei Minzu University, Enshi, Hubei 445000, P.R. China.
Zitieren
APA
Zhou, S., Sun, J., Zhu, W., Yang, Z., Wang, P., & Zeng, Y. (2024). Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review). Oncology Reports, 53(2). https://doi.org/10.3892/or.2024.8862
Vancouver
Zhou S, Sun J, Zhu W, Yang Z, Wang P, Zeng Y. Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review). Oncology Reports. 2024;53(2). doi:10.3892/or.2024.8862
BibTeX
@article{Zhou2024,
author = {Zhou, Sirui and Sun, Jiazheng and Zhu, Weijian and Yang, Zhiying and Wang, Ping and Zeng, Yulan},
title = {Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review)},
journal = {Oncology Reports},
year = {2024},
volume = {53},
number = {2},
doi = {10.3892/or.2024.8862}
}
EUVIMED